03.06.2013 Views

Brand, Identity and Reputation: Exploring, Creating New Realities ...

Brand, Identity and Reputation: Exploring, Creating New Realities ...

Brand, Identity and Reputation: Exploring, Creating New Realities ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The process of building <strong>and</strong> managing br<strong>and</strong>s in the pharmaceutical sector is a bit different to many other trades. If<br />

compared with the fashion industry, the patents are not protecting for 15 to 20 years. While in the pharmaceutical<br />

industry the patent protection usually last in between 12 to 20 years, depending upon the individual patent case in its<br />

own detail. Despite this fact, the pharmaceutical companies spend considerable amount of their sales revenues on<br />

building <strong>and</strong> promotion of br<strong>and</strong>s. One of the key logic behind this is the fact that the life of patent is 20 years<br />

(maximum) while the life of a developed br<strong>and</strong> is much more than this. For Instance Listerine is a br<strong>and</strong> of Pfizer, it is<br />

not patented but due to the br<strong>and</strong> name it is one of the star selling products for Pfizer. This means that the significance<br />

of br<strong>and</strong>ing in the pharmaceutical sector remains as high as in any other sector. These observations are the empirical<br />

realism as it contains logical defence through financial data while it is also considerate to the environment of the<br />

market. The Proposed <strong>Br<strong>and</strong></strong> Management Framework is a model that proposes the development <strong>and</strong> management of<br />

br<strong>and</strong>s with the inclusion of financial measurement <strong>and</strong> R&D activities.<br />

<strong>Br<strong>and</strong></strong>ing is one of the key responsibilities for the marketing function. It is a responsibility of the marketing department<br />

to develop <strong>and</strong> manage the br<strong>and</strong>s of the products/services <strong>and</strong> the organization. The identity of the products/services is<br />

called product br<strong>and</strong> while the identity of the organization is called corporate br<strong>and</strong>. In an overall philosophical sense<br />

br<strong>and</strong> is the trust of the consumer about the product <strong>and</strong> manufacturer regarding the quality <strong>and</strong> its overall sense of<br />

deliverable function. The initial contact between the consumer <strong>and</strong> the product is br<strong>and</strong> the functional performance will<br />

come after the br<strong>and</strong> is purchased.<br />

<strong>Br<strong>and</strong></strong> Development <strong>and</strong> br<strong>and</strong> management are interconnected terms but somewhat different to each other. <strong>Br<strong>and</strong></strong><br />

development refers to the creation <strong>and</strong> development of br<strong>and</strong> in a market. This is an initial work of development. <strong>Br<strong>and</strong></strong><br />

management is a much more broad term that includes the promotional, extension, expansion, diversification,<br />

enrichment, harvest <strong>and</strong> divestment of the br<strong>and</strong>. <strong>Br<strong>and</strong></strong> management framework is a proposed model for the<br />

development <strong>and</strong> management of br<strong>and</strong>s. The new contribution of this model is the inclusion of financial measures,<br />

Intellectual property rights, R&D initiatives, <strong>and</strong> core of br<strong>and</strong> performance for managing a corporate br<strong>and</strong> portfolio.<br />

The foundation for the proposed hypothesize is based on financial measures. For public limited companies the audited<br />

annual accounts <strong>and</strong> financial statements are the most credible source for financial data. This is even more authentic<br />

than primary collection of data through interviews. The reason is the legal obligations placed on the corporations by the<br />

financial regulatory authorities to declare the accurate information about the financial conditions of the business. The<br />

use of secondary data is fully justified in this research project. In a case where hypothesis are based on measuring the<br />

br<strong>and</strong> perception of consumers than the primary collection of data through questionnaires would be of more significant<br />

value. The testing of data in this research project is through quantitative data analysis to deal with the hypothetical<br />

options. The data analysis is according to the hypothesis requirement. The statistical data analysis for determine the<br />

comparative br<strong>and</strong> equity requires more in depth application of the statistical tools. For this research project the<br />

hypothesis are aimed at finding the significance of marketing expenditures, R&D expenditures <strong>and</strong> proportional of<br />

intangible assets on the overall commercial performance of an enterprise. The findings are used in the development of<br />

br<strong>and</strong> management framework as a model for developing <strong>and</strong> managing the corporate br<strong>and</strong> portfolio.<br />

The epistemological stance for this research is towards realism philosophy. Realism has the inclusion of logical thinking<br />

along with the viewpoint that environment is an important issue to consider that effects the situation <strong>and</strong> circumstances.<br />

The use of theory is based on mixed methods that include deduction with induction. The hypothesis is developed by<br />

reviewing the existing theoretical literature <strong>and</strong> revised by the research findings to present the br<strong>and</strong> management<br />

framework. This outcome of this research is a proposed model with the empirical observation in the pharmaceutical<br />

sector. This is a case of mixed approach on the account of deduction <strong>and</strong> induction. The Research strategy is based on<br />

the empirical study of the Pharmaceutical industry. The analysis of data collected from secondary sources is from<br />

quantitative perspective. The adopted research methodology is in reflection of the aims, questions, hypothesis <strong>and</strong> the<br />

involved variables for this research project.<br />

Key words: <strong>Br<strong>and</strong></strong>ing, <strong>Br<strong>and</strong></strong> management framework, <strong>Br<strong>and</strong></strong> Performance, <strong>Br<strong>and</strong></strong> Equity, Financial measurement of<br />

br<strong>and</strong>s, Intellectual property rights (IPR), Research& Development (R&D) pipelines, corporate br<strong>and</strong> portfolio, UK<br />

Pharmaceutical industry.<br />

Bibliography<br />

Graziano & Raulin, Research Methods, Seventh edition, 2010, Allyn & Bacon, Boston.<br />

Saunders et al, Business Research Methods, 2007, Financial Times, London.<br />

Alan Bryman , Research Methods, (2007) ,Oxford University Press, Oxford.<br />

Georgson , Strategic <strong>Br<strong>and</strong></strong> Management, 2008, Financial Times, Harlow.<br />

Kotler et al, Marketing Management,2010, Pearson prentice hall, Harlow.<br />

Percy & Elliot, Strategic <strong>Br<strong>and</strong></strong> Management, 2007, Oxford University Press, Oxford.<br />

Bainbridge D, Intellectual Property, 2010, Pearson education, Harlow.<br />

164

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!